|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
58,160,000 |
Market
Cap: |
5.82(B) |
Last
Volume: |
5,449,206 |
Avg
Vol: |
5,398,192 |
52
Week Range: |
$99.99 - $99.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hixson Harry F Jr |
Director |
|
2012-08-08 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,616 |
79,384 |
|
- |
|
Lief Jack |
Chairman, President and CEO |
|
2012-07-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,875 |
485,382 |
|
- |
|
Hoffman Robert |
SVP, Finance and CFO |
|
2012-07-05 |
4 |
S |
$11.00 |
$110,000 |
D/D |
(10,000) |
2,763 |
|
- |
|
Spector Steven W |
EVP, General Counsel & Sec |
|
2012-07-03 |
4 |
AS |
$10.05 |
$224,115 |
D/D |
(22,300) |
39,588 |
|
- |
|
Spector Steven W |
EVP, General Counsel & Sec |
|
2012-07-03 |
4 |
OE |
$4.01 |
$89,423 |
D/D |
22,300 |
61,888 |
|
- |
|
Spector Steven W |
EVP, General Counsel & Sec |
|
2012-07-02 |
4 |
AS |
$9.96 |
$1,341,182 |
D/D |
(134,365) |
39,588 |
|
- |
|
Spector Steven W |
EVP, General Counsel & Sec |
|
2012-07-02 |
4 |
OE |
$1.49 |
$355,569 |
D/D |
114,365 |
173,953 |
|
- |
|
Bielasz Jennifer Kathleen |
Sr.Dir. of Acct. & Cont. (PAO) |
|
2012-03-29 |
4 |
S |
$3.01 |
$32,697 |
D/D |
(10,800) |
4,800 |
|
- |
|
Bielasz Jennifer Kathleen |
Sr.Dir. of Acct. & Cont. (PAO) |
|
2012-03-29 |
4 |
OE |
$1.49 |
$9,313 |
D/D |
6,250 |
15,600 |
|
- |
|
Hoffman Robert |
VP, Finance and CFO |
|
2012-01-06 |
4 |
D |
$1.63 |
$245 |
D/D |
(150) |
12,144 |
|
- |
|
Hoffman Robert |
VP, Finance and CFO |
|
2012-01-06 |
4 |
A |
$1.64 |
$246 |
D/D |
150 |
12,294 |
|
- |
|
Hoffman Robert |
VP, Finance and CFOOfficer |
|
2011-08-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,144 |
|
- |
|
Bielasz Jennifer Kathleen |
Sr. Dir. of Accounting & Cont. |
|
2011-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,666 |
|
- |
|
Lief Jack |
Chairman, President and CEO |
|
2010-08-12 |
5 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
495,507 |
|
- |
|
Behan Dominic P |
SVP & Chief Scientific Officer |
|
2010-01-28 |
4 |
OE |
$0.60 |
$16,500 |
D/D |
27,500 |
423,000 |
|
- |
|
Hoffman Robert |
VP, Finance and CFO |
|
2009-06-26 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
57,731 |
|
- |
|
Lief Jack |
Chairman, President and CEO |
|
2009-06-26 |
5 |
GD |
$0.00 |
$0 |
D/D |
12,250 |
518,007 |
|
- |
|
White Christine Anna |
Director |
|
2009-05-14 |
4 |
B |
$2.62 |
$53,492 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
Woods Randall E |
Director |
|
2009-05-14 |
4 |
B |
$2.75 |
$2,750 |
D/D |
1,000 |
1,000 |
2.31 |
- |
|
Hixson Harry F Jr |
Director |
|
2009-05-14 |
4 |
B |
$2.67 |
$160,440 |
D/D |
60,000 |
90,000 |
2.39 |
- |
|
Bice Scott H |
Director |
|
2009-05-14 |
4 |
B |
$2.67 |
$10,146 |
D/D |
3,800 |
4,900 |
2.39 |
- |
|
Belcher Donald D |
Director |
|
2009-05-14 |
4 |
B |
$2.62 |
$91,700 |
D/D |
35,000 |
50,000 |
2.39 |
- |
|
Laforce James |
Director |
|
2009-05-14 |
4 |
B |
$2.74 |
$9,588 |
D/D |
3,500 |
13,500 |
2.39 |
- |
|
Behan Dominic P |
SVP & Chief Scientific Officer |
|
2009-02-09 |
4 |
OE |
$0.60 |
$36,000 |
D/D |
60,000 |
395,500 |
|
- |
|
Hoffman Robert |
VP, Finance and CFO |
|
2008-09-02 |
4 |
AS |
$6.12 |
$61,605 |
D/D |
(10,000) |
57,254 |
|
- |
|
415 Records found
|
|
Page 12 of 17 |
|
|